Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viemed Healthcare Inc (VMD)
NASDAQ:VMD
Holding VMD?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.11Last Year’s EPS
0.09Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 05, 2018
|% Change Since: -9.41%
|Next Earnings Date:Aug 13, 2018
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with record-breaking revenue, strong growth in core businesses, and positive regulatory developments. While there were pressures on gross margin and increased CapEx, the company's strategic initiatives and operational efficiencies are driving improved performance and setting a strong foundation for future growth.Company Guidance
During the Viemed Q3 2024 earnings call, the company exceeded projections with a record net revenue of $58 million, driven by organic growth and M&A activities. The CEO highlighted a 4.3% sequential increase in active vent patients and an 11% sequential increase in sleep therapy patient count to 19,478, alongside a 9.7% rise in resupply orders to 22,143. Viemed also reported a gross margin of 59.3% and an EBITDA margin of 24.1%, reflecting improved operational efficiencies and cost management. The company anticipates Q4 net revenue between $59.7 million and $60.9 million, implying a year-over-year growth of 18.9%. With the ongoing regulatory support and a robust M&A pipeline, Viemed is well-positioned for sustained growth into 2025.Record-Breaking Revenue and Growth
Viemed's third quarter net revenue reached a record $58 million, exceeding the top end of their guidance and showing strong year-over-year and sequential growth.
Vent Business Growth
The vent business showed a 4.3% sequential increase in active vent patients, with over 400 vent patients added in Q2 and Q3, attributed to operational overhaul and new sales structure.
Positive Regulatory Developments
Viemed has been a leading advocate for reconsideration of NCD 280.1, and there are positive signs of support for the industry, including potential reimbursement relief from the 75-25 rate adjustment.
EBITDA Margin Improvement
EBITDA margin for the quarter was 24.1%, up from 23.3% in the second quarter, indicating improved operational efficiencies and cost management.
Strong M&A Pipeline
The company has a robust M&A pipeline focused on complementary services to expand core businesses and enhance value to providers and payers.
---
VMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
VMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $9.14 | $9.00 | -1.53% |
| Aug 07, 2024 | $6.53 | $7.18 | +9.95% |
| May 06, 2024 | $8.22 | $7.66 | -6.81% |
| Mar 06, 2024 | $9.38 | $9.99 | +6.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Viemed Healthcare Inc (VMD) report earnings?
Viemed Healthcare Inc (VMD) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Viemed Healthcare Inc (VMD) earnings time?
Viemed Healthcare Inc (VMD) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VMD EPS forecast?
VMD EPS forecast for the fiscal quarter 2024 (Q4) is 0.11.
---
